Ping An Ventures leads $10 mln Series A for Prenetics

Ping An Ventures, the venture capital arm of Ping An Insurance Group, led a $10 million Series A investment round in Prenetics. Based in Hong Kong, Prenetics offers a test to help physicians prescribe medications and dosages based on a patient's unique genetic profile. Other investors in the round include Venturra Capital, a fund backed by Indonesia's Lippo Group, Capital Union Investments and existing investors 500 Startups and COENT Venture Partners.

Briefs